Sign in

CIK 0001831915 · Accelerated filer

Cytek Biosciences, Inc.

Sign in to watch
Ticker
CTKB
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472547526
Phone
(877) 922-9835
Business address
47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $9.92 ($198,400)
  3. 4 Shares withheld for taxes SVP Marketing and Corp. Dev. gave up 411 shares (to pay taxes)
  4. 4 Shares withheld for taxes President and CEO gave up 3,510 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 910 shares (to pay taxes)
  6. 4 Shares withheld for taxes General Counsel gave up 1,047 shares (to pay taxes)
  7. 4 Open-market sale President and CEO sold 20,000 shares at $8.01 ($160,200)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $10.34 ($206,800)
  11. 4 Open-market sale President and CEO sold 20,000 shares at $10.54 ($210,800)
  12. 4 Open-market sale Chief Technology Officer sold 20,000 shares at $11.64 ($232,800)
  13. 4 Open-market buy Director bought 583,870 shares at an average $12.31 ($7,188,926)
  14. 4 Open-market buy Director bought 634,638 shares at an average $12.86 ($8,158,671)
  15. 4 Option exercise Chief Technology Officer acquired 73,011 shares (option exercise)
  16. 4 Open-market sale President and CEO sold 20,000 shares at an average $12.65 ($253,052)
  17. 4 Option exercise General Counsel acquired 10,500 shares (option exercise)
  18. 4 Open-market buy Director bought 647,264 shares at an average $12.74 ($8,248,255)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 13 of 15 · 295 filings